Comparison of Outcomes from a Phase 3 Study of Age-Related Macular Degeneration with a Matched, Observational Cohort-Reference-Cited by-同舟云学术

Comparison of Outcomes from a Phase 3 Study of Age-Related Macular Degeneration with a Matched, Observational Cohort

Published:2014-03 Issue:3 Volume:121 Page:676-681
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Gillies Mark C.,Walton Richard J.,Arnold Jennifer J.,McAllister Ian L.,Simpson Judy M.,Hunyor Alex P.,Guymer Robyn,Essex Rohan W.,Morlet Nigel,Barthelmes Daniel

Publisher

Elsevier BV

Subject

Ophthalmology

Reference22 articles.

1. Enrichment of clinical study populations;Temple;Clin Pharmacol Ther,2010

2. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

3. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

4. As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration;Biarnes;Eur J Ophthalmol,2011

5. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration;Dadgostar;Ophthalmology,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient capture of dry eye data from the real world: The Save Sight Dry Eye Registry;AJO International;2024-10

2. Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis;Eye;2022-04-08

3. Neovascular age-related macular degeneration in which exudation predominantly occurs as a subretinal fluid during anti-vascular endothelial growth factor treatment;Scientific Reports;2022-02-24

4. Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration;Eye;2022-02-09

5. To investigate treat and extend versus pro re nata regimen in neovascular age-related macular degeneration: results from the IDEM study;Graefe's Archive for Clinical and Experimental Ophthalmology;2022-01-12